{"id":1139,"date":"2024-01-17T09:07:54","date_gmt":"2024-01-17T09:07:54","guid":{"rendered":"https:\/\/www.the-nash-education-program.com\/?page_id=1139"},"modified":"2024-01-17T09:07:54","modified_gmt":"2024-01-17T09:07:54","slug":"how-is-nash-managed","status":"publish","type":"page","link":"https:\/\/www.the-nash-education-program.com\/what-is-nash\/how-is-nash-managed\/","title":{"rendered":"HOW IS NASH MANAGED?"},"content":{"rendered":"\n
There are two key challenges when considering a NASH diagnosis. The first involves identifying at-risk patients. The second involves determining the level of risk a patient is facing. Successfully identifying a patient\u2019s current stage and their risk of progressing can help you make more confident diagnoses and treatment recommendations. The chart below offers some helpful guidelines.<\/p>\n\n\n\n
NASH treatment is rapidly changing and new, more effective treatments are on the horizon.2<\/sup> But for now, it will take awareness, vigilance, and careful risk-benefit analysis to change the lives of NASH and NAFLD patients.<\/p>\n\n\n\n Below are guidelines from the American Association for the Study of Liver Diseases (AASLD).3<\/sup> While none of the treatment options below have been approved for the treatment of NASH, it may be a good place to start.<\/p>\n\n\n\n